Page 10 - Alpha Da News Today

Piper Sandler began coverage on shares of Alpha Tau Medical (NASDAQ:DRTS – Get Rating) in a research note issued to investors on Friday morning, MarketBeat Ratings reports. The firm issued an overweight rating and a $19.00 price objective on the stock. Several other brokerages have also recently issued reports on DRTS. Citigroup started coverage on […]

Zacks Investment Research cut shares of Alpha Tau Medical (NASDAQ:DRTS – Get Rating) from a hold rating to a sell rating in a research note issued to investors on Wednesday, Zacks.com reports. According to Zacks, “Alpha Tau Medical Ltd. is a medical device company. It focuses on research, development, and potential commercialization of the Alpha […]

Citigroup initiated coverage on shares of Alpha Tau Medical (NASDAQ:DRTS – Get Rating) in a research report sent to investors on Monday morning, MarketBeat Ratings reports. The brokerage issued a buy rating and a $21.00 target price on the stock. Separately, Zacks Investment Research downgraded shares of Alpha Tau Medical from a hold rating to […]

/PRNewswire/ -- Alpha Tau Medical Ltd. (Nasdaq: DRTS) (Nasdaq: DRTSW), ("Alpha Tau" or the "Company"), the developer of the innovative alpha-radiation cancer...

The company is developing a promising type of radiation treatment for solid tumors.

The stock enjoyed another big gain.

/PRNewswire/ -- Alpha Tau Medical Ltd. (Nasdaq: DRTS), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, today announced the...

/PRNewswire/ -- Alpha Tau Medical Ltd. (Nasdaq: DRTS), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, today announced the...

/PRNewswire/ -- Alpha Tau Medical Ltd. (Nasdaq: DRTS), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, today announced the...

NEW YORK and JERUSALEM, ISRAEL , Feb. 22, 2022 (GLOBE NEWSWIRE) --  Healthcare Capital Corp. (NASDAQ: HCCC, HCCCW, and HCCCU) (“HCCC”) and Alpha Tau...